Brent Pfeiffenberger - 17 Nov 2025 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
President and CEO, Director
Signature
/s/ Douglas Carr, Attorney-in-Fact
Issuer symbol
IPSC
Transactions as of
17 Nov 2025
Transactions value $
-$14,735
Form type
4
Filing time
19 Nov 2025, 16:19:22 UTC
Previous filing
10 Sep 2025
Next filing
20 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pfeiffenberger Brent President and CEO, Director C/O CENTURY THERAPEUTICS, INC., 25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA /s/ Douglas Carr, Attorney-in-Fact 19 Nov 2025 0002001162

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IPSC Common Stock Sale -$14.7K -32.5K -0.99% $0.45 3.24M 17 Nov 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.